Home / Feature (page 2)


Gilead Sciences Inc. (NASDAQ:GILD) Will Provide Public Available To Epclusa Tablets- Community Health Systems (CYH)


Gilead Sciences Inc. (NASDAQ:GILD) [Trend Analysis] pretends to be active mover, stock reduced around -0.66% to trade at $68.83. Gilead Sciences Canada, Inc. reported, effective February 28th, 2017, Ontario will provide public access to EPCLUSA tablets, the first once-daily, pan-genotypic single tablet regimen for the treatment of adults with genotype 1-6 …

Read More »